SEC Form 4 reporting owner

Scharen-Guivel Hilda Frederique

Scharen-Guivel Hilda Frederique has filed 5 Form 4 transactions reported between December 7, 2025 and June 4, 2026, as Director of IRADIMED CORP.

Name as filed: Scharen-Guivel Hilda Frederique

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$285K
2 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 4, 2026
transaction date

Roles and reported holdings

  • IRMDIRADIMED CORP
    Dec 7, 2025 – Jun 4, 2026

    Director

    Held directly5,598 sh as of Jun 4, 2026 · Form 4

    24 months: $285K sold

Transaction history

All 5 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 4, 2026IRMDDirectorOpen-market saleCode S · direct1,234$117K@ $95.00Form 4
Jun 4, 2026IRMDDirectorOpen-market saleCode S · direct1,766$168K@ $95.00Form 4
Dec 11, 2025IRMDOption exerciseCode M · direct905—Form 4
Dec 11, 2025IRMDGrant or awardCode A · direct1,026—Form 4
Dec 7, 2025IRMDOption exerciseCode M · direct1,197—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.